Enzolytics Inc (ENZC)

[foxi]

At first glance I don't see any new info about the SAGA deal in the latest OTC filing.

The numbers for Series E preferred changed. Last filing (period ending December 31, 2022) there was 1 shareholder and 5 mil shares outstanding, now (period ending March 31, 2023) there is blank (0?) shareholders and 0 shares reported outstanding. Extrapolating from the 10 votes per share, perhaps these were converted 1:10 to 50,000,000 common. Indeed this is the case, per Page 7. Converted to common for Mt. Rose Corporation V. Dimitrov. They were restricted shares as of this reporting period, but may have become unrestricted since then. As of December 31, 2021 there were 451,289,565 restricted common shares, and as of 5/19 there are 417,089,585 restricted, showing a decrease of about 35 million. So I would assume either some of these series E conversions were made unrestricted since 3/31/23, or more likely some of the restricted shares issued pre-2022 became unrestricted.

I'm not seeing traceability for Series F Preferred. Page 47 says "Year ended December 31, 2022 During the year ended December 31, 2022, the Company issued 2,500,000 shares of Series F Preferred Stock for $1,000,000." but Page 3 shows 0 outstanding.

It's not new news, but good to see lots of positive developments listed in Subsequent Events at the end of the disclosure.